BioLASCO Taiwan Co., Ltd.
3F., No. 267, Chongyang Rd., Nangang Dist., Taipei City, , Taiwan (R.O.C.)
Tel:(02) 2651-8669
Fax:(02) 2651 – 8969
Board of Directors
| Date | Subject |
| 2024/01/25 | 1. The operational plan and budget proposal for the fiscal year 2024 of the company.
2. The application for a long-term loan to the bank. 3. Current salary and remuneration items for the company’s directors and managers. 4. The 2023 year-end bonus distribution plan for the chairman of the company. 5. Performance bonus distribution case for the company’s managers in 2023. |
| 2024/03/15 | 1. Remuneration distribution case for employees and directors in 2023.
2. 2022 business report and financial statements. 3. Surplus distribution case for 2023. 4. Evaluation and appointment case for the independence and suitability of the company’s signing accountant. 5. Issue the company’s 2023 “Internal Control System Statement”. 6. The expiration of the company’s financing loan contract with the financial institution. 7. The proposal to amend the company’s “Articles of Incorporation.” 8. The proposal to amend the company’s “Rules of Procedure for Board of Directors Meetings” and “Audit Committee Charter.” 9. The proposal regarding the appointment of the company’s new managerial and their salary and remuneration. 10. The proposal to cancel the director’s non-competition clause. 11. Agenda for convening the company’s 2024 annual general shareholders’ meeting. 12. The company accepts matters related to shareholder proposals. |
| 2024/04/25 | 1. The proposal for the company to purchase real estate in the Da-Hu Science Park.
2. The proposal to release managerial personnel from non-compete restrictions. |
| 2024/05/14 | 1. Financial report for the first quarter of 2024.
2. The company intends to apply for a real estate mortgage loan from the bank. |
| 2024/07/09 | 1. The proposal to establish the ex-dividend record date for the company’s cash dividend distribution and related matters.
2. The company’s individual remuneration distribution plan for directors in 2023. 3. Distribution of manager remuneration for the year 2023. 4. The proposal regarding the current salary and compensation items for the company’s directors and managerial. 5. Salary adjustment case for the company’s managers. 6. Director Chen Junwei’s remuneration case. 7. The proposal to remove restrictions on managerial non-competition clauses. |
| 2024/08/12 | Financial report for the second quarter of 2024. |
| 2024/11/08 | 1. Financial report for the third quarter of 2024.
2. The company’s annual internal audit plan for 2025. 3. Proposed revision of the company’s “Internal Audit Implementation Rules”. 4. The proposal to add or amend the company’s “Internal Control System” and related management regulations. |
| 2024/12/25 | 1. The operational plan and budget proposal for the fiscal year 2025 of the company.
2. The proposal regarding the change of the company’s spokesperson. |